Skip to content

Dialysate magnesium - a novel tool to abrogate dialysis-induced myocardial stunning?

A randomised controlled cross-over trial of 0.5 mmol/L versus 1.0 mmol/L dialysate magnesium to abrogate dialysis-induced myocardial stunning

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN37809057
Enrollment
24
Registered
2010-11-04
Start date
2008-06-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dialysis-induced myocardial stunning Surgery Myocardial stunning

Interventions

Each patient undergoes one week (three dialysis treatments) of standard haemodialysis, and one week (three dialysis treatments) of standard haemodialysis with supplemental oxygen to breathe
the chronological order of the two weeks is allocated by randomisation. Patients thereby act as their own controls. Monitored visits occur on the third treatment of each week. There is no further foll

Sponsors

Derby Hospitals NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Over 18 years old, either sex 2. Chronic haemodialysis greater than 3 months

Exclusion criteria

Exclusion criteria: 1. New York Heart Association (NYHA) grade IV heart failure 2. Cardiac transplant 3. Known disorder of magnesium metabolism 4. Magnesium supplementation 5. Recent arrhythmia

Design outcomes

Primary

MeasureTime frame
Development of regional wall motion abnormalities. Key observations are taken pre-dialysis (baseline), 15 minutes prior to end of dialysis (peak stress) by cardiac echocardiography (for later offline semi-automated analysis for regional wall motion abnormalities).

Secondary

MeasureTime frame
Haemodynamic variables observed pre-dialysis, and throughout dialysis treatment, with continuous non-invasive measurement by finometer, and NICOM (bioreactance).

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026